Bioequivalence of Domestic and Imported Betahistine Mesylate Tablets in Healthy Volunteers

段京莉,严宝霞,陈笑艳,钟大放
DOI: https://doi.org/10.3969/j.issn.1001-6821.2003.01.012
2003-01-01
Abstract:OBJECTIVE: To study the bioequivalence of domestic and imported betahistine mesylate in 20 healthy volunteers. METHODS: A single dose of 24 mg domestic and imported betahistine mesylate tablets were given according to an open randomized 2 way crossover design. Plasma concentration of the main metabolite of betahistine, pyridine-2-ethanoic acid, was determined by HPLC/MS/ MS method. RESULTS: The pharmacokinetics parameters of the two products were as follow: Cmax were 308.6± 208.8 and 339.4±213.4mg.L-1, tmax were 1.13 ± 0.66 and 0.98 ± 0.47h; AUC0-t were 1168.5 ± 794.9 and 1129.3 ± 725.2mg.L-1; AUC0-∞ were 1213.2 ± 819.2 and 1178.9 ± 752.5mg.L-1, respectively. The relative bioavailability of domestic production was (106.3 ± 29.1)%. CONCLUSION: The result demonstrated that two formations were bioequivalence by analysis of variance, two-one side test and 90% confidential internal.
What problem does this paper attempt to address?